News Janssen’s Imbruvica latest to gain NICE approval after price... Leukaemia drug latest cancer treatment to gain NICE approval
News Decision to axe Afinitor 'confirms worst fears’ for Cancer D... NICE reviewing 'legacy drugs' to free up CDF funds
News Imbruvica, Opdivo and Praluent gain approvals for Scotland’s... Sanofi steals a march on rivals Amgen